ATE98264T1 - Polysaccharide, extrahiert aus pflanzen und verwendet als medizinen und zusatzstoffe fuer nahrungsmittel. - Google Patents

Polysaccharide, extrahiert aus pflanzen und verwendet als medizinen und zusatzstoffe fuer nahrungsmittel.

Info

Publication number
ATE98264T1
ATE98264T1 AT88401774T AT88401774T ATE98264T1 AT E98264 T1 ATE98264 T1 AT E98264T1 AT 88401774 T AT88401774 T AT 88401774T AT 88401774 T AT88401774 T AT 88401774T AT E98264 T1 ATE98264 T1 AT E98264T1
Authority
AT
Austria
Prior art keywords
medicines
plants
food additives
polysaccharides extracted
polysaccharides
Prior art date
Application number
AT88401774T
Other languages
English (en)
Inventor
Tan Hung Nguyen
Original Assignee
Guyomarc H Nutrition Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guyomarc H Nutrition Animale filed Critical Guyomarc H Nutrition Animale
Application granted granted Critical
Publication of ATE98264T1 publication Critical patent/ATE98264T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/807—Poultry or ruminant feed
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/809—Food or edible material: processes, compositions, and products including harvesting or planting or other numerous miscellaneous processing steps
AT88401774T 1987-07-10 1988-07-07 Polysaccharide, extrahiert aus pflanzen und verwendet als medizinen und zusatzstoffe fuer nahrungsmittel. ATE98264T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8709857A FR2617848B1 (fr) 1987-07-10 1987-07-10 Polysaccharides extraits, notamment, de vegetaux utiles comme medicaments et additifs alimentaires
EP88401774A EP0304347B1 (de) 1987-07-10 1988-07-07 Polysaccharide, extrahiert aus Pflanzen und verwendet als Medizinen und Zusatzstoffe für Nahrungsmittel

Publications (1)

Publication Number Publication Date
ATE98264T1 true ATE98264T1 (de) 1993-12-15

Family

ID=9353077

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88401774T ATE98264T1 (de) 1987-07-10 1988-07-07 Polysaccharide, extrahiert aus pflanzen und verwendet als medizinen und zusatzstoffe fuer nahrungsmittel.

Country Status (10)

Country Link
US (2) US4948785A (de)
EP (1) EP0304347B1 (de)
JP (1) JPH0657721B2 (de)
AT (1) ATE98264T1 (de)
BR (1) BR8803442A (de)
DE (1) DE3886134T2 (de)
DK (1) DK377888A (de)
ES (1) ES2060666T3 (de)
FR (1) FR2617848B1 (de)
IL (1) IL86881A (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04141064A (ja) * 1990-10-03 1992-05-14 Sunamiya:Kk 薬膳調味液、薬膳調味料の製造方法
EP0970968A4 (de) * 1997-03-28 2002-01-09 Kampou Foundation Pharmakologisch aktive substanz
US6214351B1 (en) 1999-08-27 2001-04-10 Morinda, Inc. Morinda citrifolia oil
US6254913B1 (en) 1999-08-27 2001-07-03 Morinda, Inc. Morinda citrifolia dietary fiber and method
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
US20070196527A1 (en) * 2006-02-23 2007-08-23 Jensen Claude J Preventative and treatment effects of Morinda citrifolia on Osteoarthritis and its related conditions
US7048952B2 (en) * 2002-05-21 2006-05-23 Morinda, Inc. Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice
US20110171333A1 (en) * 2000-12-05 2011-07-14 Bryant Wadsworth Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products
US20120237626A9 (en) * 2000-12-05 2012-09-20 Palu Afa Kehaati Profiles of lipid proteins and inhibiting HMG-CoA reductase
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
US7244463B2 (en) * 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
US20040192761A1 (en) * 2003-03-25 2004-09-30 Palu Afa Kehaati Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US8652546B2 (en) 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
JP2005511479A (ja) * 2001-04-17 2005-04-28 モリンダ・インコーポレーテッド モリンダシトリフォリア油および果汁の緩和作用
US7070813B2 (en) * 2001-11-02 2006-07-04 Morinda, Inc. Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor
US7442395B2 (en) * 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US20110160057A1 (en) * 2001-11-14 2011-06-30 Bryant Wadsworth Morinda Citrifolia Based Antimicrobial Formulations
US20060269630A1 (en) * 2003-04-16 2006-11-30 Palu Afa K Morinda citrifolia as a 5-Lipoxygenase inhibitor
US20050106275A1 (en) * 2003-05-02 2005-05-19 Chen Su Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells
JP4073826B2 (ja) * 2003-06-04 2008-04-09 タヒチアン ノニ インターナショナル インコーポレーテッド ヤエヤマアオキの抽出物を含む農業用活力剤
US20070259060A1 (en) * 2003-08-12 2007-11-08 Mian-Ying Wang Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
US20050260291A1 (en) * 2004-03-10 2005-11-24 Palu Afa K Methods and compositions for reactivating acetylcholinesterase
US20060088611A1 (en) * 2004-09-01 2006-04-27 Paulus Wang Morinda citrifolia-based formulations and methods for weight management
US20060141076A1 (en) * 2004-11-01 2006-06-29 Palu Afa K Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase
US20060204601A1 (en) * 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
US20070122507A1 (en) * 2005-05-26 2007-05-31 Palu Afa K Histone deacetylase and tumor necrosis factor converting enzyme inhibition
US20060280818A1 (en) * 2005-05-26 2006-12-14 Palu Afa K Nicotinic acetylcholine receptor antagonist
US20070154579A1 (en) * 2005-11-29 2007-07-05 Palu Afa K Morinda Citrifolia Based Formulation And Methods For Weight Management
US20070237848A1 (en) * 2005-12-21 2007-10-11 Brad Rawson MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1beta, INTERLEUKIN-6, TNF-alpha, HLE, AND iNOS
US20070281903A1 (en) * 2006-05-04 2007-12-06 Palu Afa K Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US20080226758A1 (en) * 2006-11-28 2008-09-18 Shixin Deng Lipoxygenase and Cyclooxygenase Inhibition
US20080213415A1 (en) * 2007-02-08 2008-09-04 Palu Afa K Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations
PT103714B (pt) * 2007-04-11 2020-07-28 73100 - Setenta E Três Mil E Cem, Lda. Processo para a obtenção de um polímero à base de galactose
US20080317890A1 (en) * 2007-06-21 2008-12-25 Claude Jarakae Jensen Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical
US20090196944A1 (en) * 2008-02-01 2009-08-06 Brad Rawson Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS
US8748123B2 (en) 2009-12-15 2014-06-10 73100-Setenta e Tres Mil e Cem, Lda. Fucose-containing bacterial biopolymer
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670523A (de) * 1964-10-09
FR2513518A1 (fr) * 1981-09-29 1983-04-01 Tubery Pierre Polysaccharide extrait du gnidia kraussiana, preparation et usages therapeutiques
HU188311B (en) * 1982-03-04 1986-04-28 Szendrei,Kalman,Hu Process for producing biologically active polisaccharide concentrates and pharmaceutical compositions containing them as active agents

Also Published As

Publication number Publication date
DK377888D0 (da) 1988-07-07
ES2060666T3 (es) 1994-12-01
US5110803A (en) 1992-05-05
EP0304347B1 (de) 1993-12-08
EP0304347A2 (de) 1989-02-22
US4948785A (en) 1990-08-14
EP0304347A3 (en) 1989-03-08
FR2617848B1 (fr) 1990-01-05
DK377888A (da) 1989-01-11
DE3886134D1 (de) 1994-01-20
BR8803442A (pt) 1989-01-31
JPS6431801A (en) 1989-02-02
JPH0657721B2 (ja) 1994-08-03
DE3886134T2 (de) 1994-04-21
IL86881A0 (en) 1988-11-30
IL86881A (en) 1992-06-21
FR2617848A1 (fr) 1989-01-13

Similar Documents

Publication Publication Date Title
ATE98264T1 (de) Polysaccharide, extrahiert aus pflanzen und verwendet als medizinen und zusatzstoffe fuer nahrungsmittel.
ES2051768T5 (es) Compuestos farmaceuticos mejorados con contenido de metales.
DK0561089T3 (da) Hypocariogen hydrogeneret saccharidsammensætning samt fremgangsmåde til fremstilling og anvendelse af denne sammensætning.
DE3785279T2 (de) Waesserige polysaccharid-zusammensetzungen.
FR2594438B1 (fr) Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
DE3071370D1 (en) Oligosaccharide fractions and oligosaccharides with biological properties, process for their preparation and their uses as medicines
NO922344L (no) Gel
ATE148471T1 (de) Polysaccharide aus glykogen
FI853095L (fi) Foerfarande foer aotervinning av en gelbildande polysackarid, aotervunnen polysackarid och gel bildad daermed.
FR2665167B1 (fr) Composition comportant un polysaccharide obtenu par fermation microbiemnne. pa
KR880001222A (ko) 동물사료
FI943242A0 (fi) Lääke munuais- ja maksatauteihin
IT1186667B (it) 2,1,3-benzotiadiazoli e 2,1,3-benzossadiazoli,loro preparazione e loro applicazione come medicamenti
BE892287A (fr) Alcools heterocycliques et derives fonctionnels, ainsi que leur procede de preparation
DE69111119D1 (de) Durch Fermentation hergestellte Polysaccharide.
KR870007088A (ko) 인분을 주제로한 효성비료제법
DE59009626D1 (de) Basische Polysaccharide.
ES263063U (es) "una variedad nueva y distinta de arbol del aguacate".
IT8220819A0 (it) Derivati diossazabiciclici,loro procedimento di preparazione e loro applicazione in terapia.
KR870009787A (ko) 관 연결구의 가공방법
KR910016277A (ko) 생약제를 활용한 볶은 소금을 제조하는 방법
Lipkind et al. Theoretical conformational analysis of specific O-antigenic polysaccharides. V. Disaccharide fragments from Salmonella typhimurium polysaccharide.
KR900015640A (ko) 죽 염(대나무 소금)
KR900017493A (ko) 올리고당을 함유하는 동물사료
KR900017604A (ko) 남천촉 열매 추출물-함유 인후용 제제

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee